Description: It is an intermediate for Entrectinib and Tazemetostat. Entrectinib is an anti-cancer medication used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors. Tazemetostat, is a medication used for the treatment of adults and adolescents aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. It may help keep the cancer cells from growing.